An Open-Label, Multicenter, Expanded Access Study of Oral AMN 107 in Adult Patients With Imatinib (Glivec®/Gleevec®_ - Resistant or Intolerant Chronic Myeloid Leukemia in Blast Crisis, Accelerated Phase or Chronic Phase

NCT00538109 · clinicaltrials.gov ↗
NA
Phase
COMPLETED
Status
8
Enrollment
OTHER
Sponsor class

Conditions

Interventions

Sponsor

King Faisal Specialist Hospital & Research Center